Display of functional thrombin inhibitor hirudin on the surface of phage M13

Gene

Volumn 204, Issue 1-2, 1997, Pages 177-184

  Wirsching, Frank ^a   Opitz, Thomas ^a   Dietrich, Rüdiger ^a   Schwienhorst, Andreas ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

C terminal extension; Fluorogenic assay; Hirudin; Phage display; pIII fusion protein; Thrombin inhibitor

Indexed keywords

HIRUDIN; HYBRID PROTEIN; SYNTHETIC DNA; THROMBIN; THROMBIN INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIOPHAGE M13; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; NONHUMAN; PHAGE DISPLAY; PHAGEMID; PRIORITY JOURNAL; STEREOSPECIFICITY;

BACTERIOPHAGE M13; CAPSID; CLONING, MOLECULAR; HIRUDINS; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; THROMBIN;

UNIDENTIFIED BACTERIOPHAGE;

EID: 0031578799     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00540-4     Document Type: Article

References (50)

1. Benatti L., Scacheri E., Bishop D.H.L., Sarmientos P. Secretion of biologically active leech hirudin from baculovirus-infected insect cells. Gene. 101:1991;255-260.
2. Bergmann C., Dodt J., KÖhler S., Fink E., Gassen H.G. Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis. Biol. Chem. Hoppe-Seyler. 367:1968;731-740.
3. Björk I., Lindhal V. Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem. 48:1982;161-182.
4. Boneu B. New antithrombotic agents for the prevention and treatment of deep vein thrombosis. Haemostasis. 26:1996;368-378.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Braun P.J., Dennis S., Hofsteenge J., Stone S.R. Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin. Biochemistry. 27:1988;6517-6522.
7. Chang J.-Y., Ngai P.K., Rink H., Dennis S., Schlaeppi J.-M. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail. FEBS Lett. 261:1990;287-290.
8. Clackson T., Wells J.A. In vitro selection from protein and peptide libraries. TIBTECH. 12:1994;173-183.
9. Crameri R., Suter M. Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production. Gene. 137:1993;69-75.
10. Daugherty B.L., DeMartino J.A., Law M.-F., Kawka D.W., Singer I.I., Mark G.E. Polymerase chain reaction facilitates the cloning, CDR-grafting and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins. NAR. 19:1991;2471-2476.
11. Degryse E., Acker M., Defreyn G., Bernat A., Maffrand J.P., Roitsch C., Courtney M. Point mutations modifying the thrombin inhibition kinetics and antithrombotic activity in vivo of recombinant hirudin. Prot. Eng. 2:1989;459-465.
12. Dennis M.S., Herzka A., Lazarus R.A. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display. J. Biol. Chem. 270:1995;25411-25417.
13. Dennis M.S., Lazarus R.A. Kunitz domain inhibitors of tissue factor-factor VIIa. J. Biol. Chem. 269:1994;22129-22136.
14. Dodt J., Müller H.-P., Seemüller U., Chang J.-Y. The complete amino acid sequence of hirudin, a thrombin-specific inhibitor. FEBS Lett. 165:1984;180-183.
15. Dodt J., Seemüller U., Maschler R., Fritz H. The complete covalent structure of Hirudin. Biol. Chem. Hoppe-Seyler. 366:1985;379-385.
16. Egner U., Hoyer G.A., Schleuning W.D. Rational design of hirulog-type inhibitors of thrombin. J. Comput. Aided Mol. Design. 8:1994;479-490.
17. Fortkamp E., Rieger M., Heisterberg-Moutses G., Schweitzer S., Sommer R. Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech. DNA. 5:1986;511-517.
18. Fox I., Dawson A., Loynds P., Eisner J., Findlen K., Levin E., Hanson D., Mant T., Wagner J., Maraganore J. Anticoagulant activity of Hirulog (TM), a direct thrombin inhibitor in humans. Thromb. Haemostasis. 69:1993;157-163.
19. Gan Z.R., Li Y., Chen Z., Lewis S.D., Shafer J.A. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J. Biol. Chem. 269:1994;1301-1305.
20. Grütter M.G., Priestle J.P., Rahuel J., Grossenbacher H., Bode W., Hofsteenge J., Stone S.R. Crystal structure of the thrombin-hirudin complex: novel mode of serine protease inhibition. EMBO J. 9:1990;2361-2365.
21. Harvey R.P., Degryse E., Stefani L., Schamber F., Cazenave J.-P., Courtney M., Tolstoshev P., Lecocq J.-P. Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech Hirudo medicinalis. Proc. Natl. Acad. Sci. USA. 83:1986;1084-1088.
22. Jackson, R.H., McCafferty, J., Johnson, K.S., Pope, A.R., Roberts, A.J., Chiswell, D.J., Clackson, T.P., Griffiths, A.D., Hoogenboom, H.R., Winter, G., 1992. Selection of variants of antibodies and other protein molecules using display on the surface of bacteriophage fd. In: Rees, A.R., Sternberg, M.J.E., Wetzel, P. (Eds.), Protein Engineering - A Practical Approach. IRL Press, Oxford, 1992.
23. Knapp A., Degenhardt T., Dodt J. Hirudisins. J. Biol. Chem. 267:1992;24230-24234.
24. 45-65. FEBS Lett. 211:1987;10-16.
25. Laemmli U.K. Cleavage of structural protein during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
26. Lijnen H.R., Wnendt S., Schneider J., Janocha E., Van Hoef B., Collen D., Steffens G.J. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Eur. J. Biochem. 234:1995;350-357.
27. Loison G., Findeli A., Bernard S., Nguyen-Juilleret M., Marquet M., Riehl-Bellon N., Carvallo D., Guerra-Santos L., Brown S.W., Courtney M., Roitsch C., Lemoine Y. Expression and secretion in S. cerevisiae of biologically active leech hirudin. Bio/Technology. 6:1988;72-77.
28. Makowski L. Phage display: structure, assembly and engineering of filamentous bacteriophage M13. Curr. Opin. Struct. Biol. 4:1994;225-230.
29. Mao S.J., Yates M.T., Blankenship D.T., Cardin A.D., Krstenansky J.L., Lovenberg W., Jackson R.L. Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech. Anal. Biochem. 161:1987;514-518.
30. Maraganore J.M., Bourdon P., Jablonski K.L., Ramachandran K.L., Fenton II J.W. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 29:1990;7095-7101.
31. Maraganore J.M., Chao B., Joseph M.L., Jablonski J., Ramachandran K.L. Anticoagulant activity of synthetic hirudin peptides. J. Biol. Chem. 264:1989;8692-8698.
32. Markland W., Ley A.C., Ladner R.C. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin. Biochemistry. 35:1996;8058-8067.
33. Markland W., Ley A.C., Lee S.W., Ladner R.C. Iterative optimization of high-affinity protease inhibitors using phage display. 1. Plasmin. Biochemistry. 35:1996;8045-8057.
34. Markwardt F. Die Isolierung und chemische Charakterisierung des Hirudins. Hoppe-Seyler's Z. Physiol. Chem. 308:1957;147-156.
35. Pannekoek H., Mejer M.v., Schleef R.R., Loskutoff D.J., Barbas III C.F. Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis. Gene. 128:1993;135-140.
36. Phaneuf M.D., Ito R.K., LoGerfo F.W. Synthesis and characterization of a recombinant hirudin-albumin complex. Blood Coagulation and Fibrinolysis. 5:1994;641-645.
37. Phaneuf M.D., Ozaki C.K., Johnstone M.T., Loza J.-P., Quist W.C., LoGerfo F.W. Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties. Thrombosis and Haemostasis. 71:1994;481-487.
38. Roberts B.L., Markland W., Ley A.C., Kent R.B., White D.W., Guterman S.K., Ladner R.C. Directed evolution of a protein selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. Proc. Natl. Acad. Sci. USA. 89:1992;2429-2433.
39. Roberts B.L., Markland W., Siranosian K., Saxena M.J., Guterman S.K., Ladner R.C. Protease inhibitor display M13 phage: selection of high-affinity neutrophil elastase inhibitors. Gene. 121:1992;9-15.
40. Rydel T.J., Ravichandran K.G., Tulinsky A., Bode W., Huber R., Roitsch C., Fenton II J.W. The structure of a complex of recombinant hirudin and human α-thrombin. Science. 249:1990;277-280.
41. Silbernagel, S., Despopoulos, A., 1992. Taschenatlas der Physiologie, 4 ed. Thieme, Stuttgart-New York.
42. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228:1985;1315-1317.
43. Stone S.R., Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 25:1986;4622-4628.
44. Szewczuk Z., Gibbs B.F., Yue S.Y., Purisima E.O., Konishi Y. Conformationally restricted thrombin inhibitors resistant to proteolytic digestion. Biochemistry. 31:1992;9132-9140.
45. Tanaka A.S., Sampaio C.A.M., Fritz H., Auerswald E.A. Functional display and expression of chicken cystatin using a phagemid system. Biochem. Biophys. Res. Com. 214:1995;389-395.
46. Turple A.G., Weitz J.I., Hirsh J. Advances in antithrombotic therapy: novel agents. Thromb. Haemost. 74:1995;565-571.
47. Vandenbos A.A., Deckers J.W., Heyndrick G.R., Laarman G.J., Surypranata H., Zijlstra F., Close P., Rijnierse J.J.M.M., Buller H.R., Serruys P.W. Safety and efficacy of recombinant hirudin (CGP-39393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation. 88:1993;2058-2066.
48. Wallace A., Dennis S., Hofsteenge J., Stone S.R. Contribution of the N-terminal region of hirudin to its interaction with thrombin. Biochemistry. 28:1989;10079-10084.
49. Wang C.I., Yang Q., Craik C.S. Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin. J. Biol. Chem. 270:1995;12250-12256.
50. Wang C.I., Yang Q., Craik C.S. Phage display of proteases and macromolecular inhibitors. Meth. Enzymol. 267:1996;52-68.